John J. Sperzel III - 04 Nov 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chairman, President & CEO, Director
Signature
/s/ John Sprague, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
04 Nov 2024
Net transactions value
$0
Form type
4
Filing time
02 Jan 2025, 18:13:04 UTC
Previous filing
27 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +490,000 $0.000000 490,000 04 Nov 2024 Common Stock 490,000 Direct F1, F2
transaction TTOO Restricted Stock Units Award $0 +490,000 $0.000000 490,000 04 Nov 2024 Common Stock 490,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On November 4, 2024, the reporting person was granted 490,000 RSU's that vest in one installment on May 4, 2025. This grant was contingent on stockholder approval of the amendment and restatement of Issuer's 2014 Incentive Award Plan. The Issuer's stockholders approved the amendment and restatement of the plan on December 30, 2024.
F3 On November 4, 2024, the reporting person was granted 490,000 RSU's that vest in three equal annual installments beginning on November 4, 2025. This grant was contingent on stockholder approval of the amendment and restatement of Issuer's 2014 Incentive Award Plan. The Issuer's stockholders approved the amendment and restatement of the plan on December 30, 2024.

Remarks:

Chairman, President & CEO